More articles from Hematology Tumors I

You have access
Hodgkin lymphoma after first line therapy: Do we need FDG-PET/CT surveillance?
U Petrausch, TF Hany, P Veit, JD Soyka, P Samaras, C Renner, A Mischo, A Knuth, GK vonSchulthess and NG Schaefer

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 48;
You have access
Sensitivity of FDG PET/CT for initial evaluation of rare lymphomas varies depending on histology
Maroun Karam, Sumit Shah and Samantha Shankar

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 52;
You have access
Disproportional increase in thymidine uptake relative to tumor cell proliferation in indolent NHLs indicates enhanced DNA repair
Malik Juweid, Andreas Buck, Felix Mottaghy, Laura Ponto and Peter Moller

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 49;
You have access
Clinical significance of post-ABVD PET/CT findings in Hodgkin's lymphoma (HL)
T Vassilakopoulos, G Pangalis, S Masouridis, E Dimitriadou, A Gouliamos, V Prassopoulos, L Gogou, R Efthimiadou, I Andreou and M Angelopoulou

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 53;
You have access
Different FDG uptake in extranodal marginal zone MALT lymphomas according to primary sites of lymphoma involvement
Jin Ho Bae, Hyeok Kim, Hwoon-Young Jung, Cheolwon Suh and Jin-Sook Ryu

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 54;
You have access
Role of FDG PET-CT in restaging of Hodgkin's lymphoma
Tushar Mohapatra, SA Shamim, Anita Kumari, Rakesh Kumar, K Sellam, Chandershekhar Bal and A Malhotra

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 50;
You have access
Early FDG PET/CT in predicting final therapy outcome in pediatric lymphoma
Punit Sharma, Rakesh Kumar, Sameer Bakhshi, Rajender Kumar, Chandrashekhar Bal and A. Malhotra

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 51;

Main menu

User menu

Search

More articles from Hematology Tumors I